The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

BACKGROUND: In patients with multiple myeloma, renal impairment (RI) at the time of diagnosis is associated with poor survival. To the authors' knowledge, the current retrospective analysis presented is the first to assess the impact of various degrees of renal dysfunction on safety and efficac...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dimopoulos, Meletios, Alegre, Adrian, Stadtmauer, Edward A, Goldschmidt, Hartmut, Zonder, Jeffrey A, de Castro, Carlos M, Masliak, Zvenyslava, Reece, Donna, Olesnyckyj, Marta, Yu, Zhinuan, Weber, Donna M
Formato: Artigo
Idioma:Inglês
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2010
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2970911/
https://ncbi.nlm.nih.gov/pubmed/20564094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25139
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares